NEA Management Company’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-419,100
| Closed | -$926K | – | 44 |
|
|
2024
Q1 | $926K | Buy |
+419,100
| New | +$926K | 0.06% | 41 |
|
|
2023
Q1 | – | Sell |
-3,246,785
| Closed | -$4.32M | – | 56 |
|
|
2022
Q4 | $4.32M | Hold |
3,246,785
| – | – | 0.24% | 41 |
|
|
2022
Q3 | $5.07M | Hold |
3,246,785
| – | – | 0.25% | 42 |
|
|
2022
Q2 | $5M | Hold |
3,246,785
| – | – | 0.26% | 44 |
|
|
2022
Q1 | $8.31M | Sell |
3,246,785
-3,215
| -0.1% | -$8.23K | 0.24% | 45 |
|
|
2021
Q4 | $9.52M | Buy |
+3,250,000
| New | +$9.52M | 0.19% | 46 |
|